Although not tested in carcinoma cells, evidence also points to a role for TLR2 in protecting cells from genotoxic insults by limiting damaging inflammation and maintaining the assembly of p-glycoprotein (p-gp), a drug efflux transporter pump, which is expressed in myeloid and epithelial cells among other cell types [219]. This evidence concerns the gene TLR2 and carcinoma.